Inozyme Pharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Inozyme Pharma, Inc. has filed 378 SEC EDGAR filings since 05 Jan 2017

SEC filing history

Showing 276-300 of 378 matching filings.

Per page
25
Current page
12
4

FORM 4 SUBMISSION

Filing date
01 Feb 2021
Reporting date
28 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jan 2021
Reporting date
13 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jan 2021
Reporting date
13 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jan 2021
Reporting date
13 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jan 2021
Reporting date
13 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jan 2021
Reporting date
13 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39397

8-K

Filing date
12 Nov 2020
Reporting date
12 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91586

SC 13D/A

Filing date
05 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39397

8-K

Filing date
03 Sep 2020
Reporting date
03 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91586

SC 13D

Filing date
07 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91586

SC 13G filing

Filing date
06 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91586

SC 13D

Filing date
04 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91586

SC 13D

Filing date
29 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .